Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?

QR Code

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?

Bibliographic Details
Main Authors:	Catapano, A., Pirillo, A., Norata, Giuseppe
Format:	Journal Article
Published:	2017
Online Access:	http://hdl.handle.net/20.500.11937/57783

Similar Items

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice
by: Sala, F., et al.
Published: (2014)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005
by: Teng, T.H., et al.
Published: (2012)

Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)

Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)

Vanillin rich fraction regulates LDLR and HMGCR gene expression in HepG2 cells.
by: Ismail, Maznah, et al.
Published: (2010)

Gene silencing approaches for the management of dyslipidaemia
by: Norata, Giuseppe, et al.
Published: (2013)

Association of LDLR, TP53 and MMP9 gene polymorphisms with atherosclerosis in a Malaysian study population
by: Ahmad, Zalinah, et al.
Published: (2023)

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)

HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)

HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)

Sex disparities in risk and risk factors for ischemic heart disease in the Asia-Pacific region
by: Peters, S., et al.
Published: (2014)

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

Chronic Heart Failure
by: Davidson, Patricia, et al.
Published: (2008)

The Association between Urban Form and Ischemic Heart Disease: Evidence from Brisbane, Australia
by: Gudes, Ori, et al.
Published: (2015)

The study of border zone formation in ischemic heart using electro-chemical coupled computational model
by: Wan N., Wan Ab Naim, et al.
Published: (2020)

Importance of predictors of rehospitalisation in heart failure: A survey of heart failure experts
by: Betihavas, Vasiliki, et al.
Published: (2013)

Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot
by: Tan, C., et al.
Published: (2022)

The role of b-type natriuretic peptide in heart failure management
by: Newton, Phillip, et al.
Published: (2009)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
by: Hilkens, Nina A., et al.
Published: (2018)

Heart failure following oncological treatment
by: Marangou, J., et al.
Published: (2018)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

Functionalising and Preserving Blood Platelets for Biologically Targeted Gene Therapies
by: Al athram, Nairouz
Published: (2025)